Skip to main content
. 2022 Aug 5;12:13508. doi: 10.1038/s41598-022-17752-5

Figure 3.

Figure 3

Effects of Docetaxel on two-dimensional and three-dimensional cell models. (a,b) Proliferation assays for a two-dimensional monolayer and a three-dimensional spheroid, for the prostate cancer cell line PC-3, treated with docetaxel. (c,d) Cell cycle analysis of a (c) monolayer and (d) spheroids of PC-3 cells treated with the GR50 dose of docetaxel, calculated per modality.